Major Review Of EU Pharmaceutical Legislation Kicks Off
Executive Summary
The European Commission has launched the process for reshaping and addressing the long-standing weakness in the EU’s pharmaceutical legislation. It has listed in a roadmap the issues it wants to address as it considers policy options for reforms.
You may also be interested in...
European Commission Steps Further Towards ‘Ambitious’ Pharma Legislation Reform
The incentives system, access to medicines, future proofing for novel products and antimicrobial resistance are just some of the topics included in a new consultation.
European Commission Steps Further Towards ‘Ambitious’ Pharma Legislation Reform
The incentives system, access to medicines, future proofing for novel products and antimicrobial resistance are just some of the topics included in a new consultation.
EU Parliament Wants Two-Tier Database To Monitor Drug Supplies
High-level negotiations are due to begin later this month on a draft regulation that will give the European Medicines Agency new powers to tackle supply chain issues amid health emergencies.